UnitedHealth Group (UNH) beat expectations in Q1 FY2026 on revenue of $111.7B versus the $109.4B estimate (+2.0% YoY) and EPS of $7.23. The next UnitedHealth Group (UNH) earnings date is Jul 16, 2026. Below is the full UnitedHealth Group earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
UnitedHealth Group (UNH) Earnings Analysis — key stats
Next earnings date
Jul 16, 2026
Latest reported quarter
Q1 FY2026
Earnings verdict
Beat
EPS beat rate
4 of last 8 (quarters above estimate)
Avg next-day move
±10.6% (over the last 8 reports)
Post-earnings direction
Up 2 / Down 6 (of the last 8 reports)
Implied move (next report)
±4.9% (options-derived · into Jul 16, 2026)
Revenue
$111.7B (vs $109.4B est · +2.1% surprise · +2.0% YoY)
EPS
$7.23 (vs $6.58 est · +9.9% surprise · -0.1% YoY)
Share price
$425.36 (-0.3%)
Market cap
$386.3B
UnitedHealth Group (UNH) Earnings Analysis — beat / miss history
Quarter
Revenue
EPS
EPS surprise
Next-day move
Verdict
Q2 2026
$111.7B vs $109.4B est
$7.23 vs $6.58 est
+9.9%
+9.3%
Beat
Q1 2026
$113.2B vs $113.8B est
$2.11 vs $2.10 est
+0.5%
-16.4%
In line
Q4 2025
$113.2B vs $113.0B est
$2.92 vs $2.80 est
+4.3%
-2.9%
Mixed
Q3 2025
$111.6B vs $111.5B est
$4.08 vs $4.45 est
-8.3%
-5.7%
Mixed
Q2 2025
$109.6B vs $111.6B est
$7.20 vs $7.29 est
-1.2%
-27.3%
In line
Q1 2025
$100.8B vs $101.6B est
$6.81 vs $6.74 est
+1.0%
-6.2%
In line
Q4 2024
$99.2B vs $99.1B est
$7.15 vs $7.00 est
+2.1%
-5.6%
Mixed
Q3 2024
$97.9B vs $98.8B est
$6.80 vs $6.65 est
+2.3%
+11.2%
Mixed
What you'll find
Next UnitedHealth Group (UNH) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment UnitedHealth Group reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in UnitedHealth Group (UNH)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is UnitedHealth Group's next earnings date?
UnitedHealth Group's (UNH) next scheduled earnings date is Jul 16, 2026. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did UnitedHealth Group (UNH) beat or miss earnings?
In Q1 FY2026, UnitedHealth Group (UNH) posted beat results — revenue of $111.7B versus the $109.4B estimate (+2.1% surprise) and EPS of $7.23 versus $6.58 expected (+9.9% surprise). Magnisto decodes every UnitedHealth Group (UNH) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
How often does UnitedHealth Group beat earnings estimates?
Over its last 8 reported quarters, UnitedHealth Group (UNH) beat Wall Street EPS estimates 4 times, most recently a beat result in Q2 2026. Magnisto tracks every UnitedHealth Group (UNH) quarter's revenue and EPS versus consensus and grades each one Beat, Miss, In-line or Mixed at a unified ±2% threshold.
How much does UnitedHealth Group stock move after earnings?
Over its last 8 quarterly reports, UnitedHealth Group (UNH) moved an average of ±10.6% the day after earnings — ranging from -27.3% (Q2 2025) to +11.2% (Q3 2024). The stock rose after 2 of those 8 reports and fell after 6. Heading into its next report on Jul 16, 2026, options-implied volatility is pricing in a move of roughly ±4.9% (derived). Magnisto tracks the realized post-earnings move for every UnitedHealth Group (UNH) quarter alongside the beat/miss verdict — past moves don't predict the next one.
What is the forecast for UnitedHealth Group (UNH) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for UnitedHealth Group (UNH), anchored to the current $425.36 share price, so you can weigh the bull, base and bear cases for UnitedHealth Group side by side.
Is UnitedHealth Group (UNH) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether UnitedHealth Group fits your own thesis and risk profile. This is research, not investment advice.